$GHRS on watch for big dips! 👀🔥
Phase 2b trial success for TRD 🧠💊
Stock up 83%+—profit takers could hit soon 📉⚡
Strong safety & remission rates—long-term potential 📈
Let’s see if dip buyers step in! 🚀 #GHRS#Biotech#Stocks#Momentum
BREAKING NEWS for GH Research PLC -13.1%:
GH Research PLC's stock has sharply declined today. Despite this, its Phase 2b trial for GH001 remains on track for Q3 2024.
$GHRS#GHRS#GHResearchapp.marketreader.com/ticker/…